Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Nakajima

Showing results (1-10 of 288) with videos related to

Pageof 29
Sort By:
Current Opinion in Molecular Therapeutics|November 29, 2007
Smoking behavior and related cancers: the role of CYP2A6 polymorphismsMiki Nakajima
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2012
[Role of microRNAs in the regulation of cytochrome P450s and transcriptional factors]Miki Nakajima
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2017
From the Viewpoint of Drug Metabolism ResearchMiki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2022
Adenosine-to-Inosine RNA Editing and <i>N</i> <sup>6</sup>-Methyladenosine Modification Modulating Expression of Drug Metabolizing EnzymesMasataka Nakano, Miki Nakajima
Annual Review of Pharmacology and Toxicology|November 30, 2012
microRNAs as mediators of drug toxicityTsuyoshi Yokoi, Miki Nakajima
International Journal of Clinical Oncology|February 25, 2005
Cancer pharmacogenomics: achievements in basic researchMiki Nakajima, Tsuyoshi Yokoi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 17, 2019
[Most recent findings on microRNA-dependent regulation of drug metabolism]Masataka Nakano, Miki Nakajima
Drug Metabolism and Pharmacokinetics|September 6, 2005
Interindividual variability in nicotine metabolism: C-oxidation and glucuronidationMiki Nakajima, Tsuyoshi Yokoi
Pharmacology & Therapeutics|July 19, 2017
Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamicsMasataka Nakano, Miki Nakajima
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2018
Current knowledge of microRNA-mediated regulation of drug metabolism in humansMasataka Nakano, Miki Nakajima
Pageof 29

Showing results (1-10 of 288) with videos related to

Sort By:
Pageof 29
Current Opinion in Molecular Therapeutics|November 29, 2007
Smoking behavior and related cancers: the role of CYP2A6 polymorphismsMiki Nakajima
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2012
[Role of microRNAs in the regulation of cytochrome P450s and transcriptional factors]Miki Nakajima
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 2, 2017
From the Viewpoint of Drug Metabolism ResearchMiki Nakajima
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2022
Adenosine-to-Inosine RNA Editing and <i>N</i> <sup>6</sup>-Methyladenosine Modification Modulating Expression of Drug Metabolizing EnzymesMasataka Nakano, Miki Nakajima
Annual Review of Pharmacology and Toxicology|November 30, 2012
microRNAs as mediators of drug toxicityTsuyoshi Yokoi, Miki Nakajima
International Journal of Clinical Oncology|February 25, 2005
Cancer pharmacogenomics: achievements in basic researchMiki Nakajima, Tsuyoshi Yokoi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 17, 2019
[Most recent findings on microRNA-dependent regulation of drug metabolism]Masataka Nakano, Miki Nakajima
Drug Metabolism and Pharmacokinetics|September 6, 2005
Interindividual variability in nicotine metabolism: C-oxidation and glucuronidationMiki Nakajima, Tsuyoshi Yokoi
Pharmacology & Therapeutics|July 19, 2017
Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamicsMasataka Nakano, Miki Nakajima
Expert Opinion on Drug Metabolism & Toxicology|May 3, 2018
Current knowledge of microRNA-mediated regulation of drug metabolism in humansMasataka Nakano, Miki Nakajima
Pageof 29